A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal

P. Karki*, S. Koirala, S. C. Parija, S. G. Hansdak, M. L. Das

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)


Twenty-seven cases of Kala-azar were treated with sodium stibogluconate at a dose of 20 mg/ kg/day for 20 days (group A) and an equal number of cases were treated with the same dose but for a longer duration of 30 days (group B). Clinical and laboratory evaluation of these cases were carried out before and after therapy, during a follow up of cases every month, upto 6 months. Renal and liver function tests and electrocardiography were carried out of monitor any toxic effect of the drug during therapy. The cure rates of patients were 77.78% and 92.59% in group A and B cases respectively. Six and two patients in group A and B respectively were unresponsive to the treatment and showed relapse. Results of the study show that treatment of cases of Kala-azar with sodium stibogluconate in a dosage of 20 mg/kg/day for a longer period of 30 days is effective with a higher cure rate and minimum side effects, for treatment of cases of Kala-azar in this eastern part of Nepal, endemic for the disease.

Original languageEnglish
Pages (from-to)154-158
Number of pages5
JournalSoutheast Asian Journal of Tropical Medicine and Public Health
Issue number1
Publication statusPublished - Mar 1998
Externally publishedYes

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal'. Together they form a unique fingerprint.

Cite this